Christopher J. Kirk, President and CSO at Kezar Life Sciences, Inc. (KZR), bought 5,000 shares at $4.97 ($25K) on 2019-08-09, disclosed to the SEC on 2019-08-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |